| scholarly article | Q13442814 |
| P50 | author | Benoît Pinson | Q56084656 |
| Delphine Albrecht | Q57118175 | ||
| Johanna Ceschin | Q67226703 | ||
| P2093 | author name string | Jim Dompierre | |
| Bertrand Daignan-Fornier | |||
| Florian Gueniot | |||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| RAD6-Mediated transcription-coupled H2B ubiquitylation directly stimulates H3K4 methylation in human cells | Q24321262 | ||
| Regulation of chromatin remodeling by inositol polyphosphates | Q24546253 | ||
| Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma | Q24630610 | ||
| AMPK and PPARdelta agonists are exercise mimetics | Q24652674 | ||
| ADP Regulates SNF1, the Saccharomyces cerevisiae Homolog of AMP-Activated Protein Kinase | Q27675159 | ||
| The retinoblastoma protein and cell cycle control | Q27860722 | ||
| The role of chromatin during transcription | Q27860995 | ||
| Chromatin modifications and their function | Q27861067 | ||
| The Set1 methyltransferase opposes Ipl1 aurora kinase functions in chromosome segregation | Q27930816 | ||
| Cyclin Cln3 is retained at the ER and released by the J chaperone Ydj1 in late G1 to trigger cell cycle entry. | Q27931204 | ||
| Bre1, an E3 ubiquitin ligase required for recruitment and substrate selection of Rad6 at a promoter | Q27933859 | ||
| Histone H2BK123 monoubiquitination is the critical determinant for H3K4 and H3K79 trimethylation by COMPASS and Dot1. | Q37309152 | ||
| Histone H2B ubiquitination: the cancer connection | Q37361776 | ||
| Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK. | Q37543714 | ||
| The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis | Q38015891 | ||
| 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranosyl 5'-Monophosphate (AICAR), a Highly Conserved Purine Intermediate with Multiple Effects | Q38222605 | ||
| Histone core modifications regulating nucleosome structure and dynamics | Q38260208 | ||
| Physiological and toxic effects of purine intermediate 5-amino-4-imidazolecarboxamide ribonucleotide (AICAR) in yeast | Q38264137 | ||
| The histone H2B monoubiquitination regulatory pathway is required for differentiation of multipotent stem cells | Q39334659 | ||
| The E2 ubiquitin conjugase Rad6 is required for the ArgR/Mcm1 repression of ARG1 transcription | Q39406784 | ||
| The H2B ubiquitin ligase RNF40 cooperates with SUPT16H to induce dynamic changes in chromatin structure during DNA double-strand break repair. | Q39452101 | ||
| Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2B. | Q39485644 | ||
| Regulation of homologous recombination by RNF20-dependent H2B ubiquitination. | Q39583815 | ||
| 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase | Q40370485 | ||
| Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line | Q40780866 | ||
| The N-terminal domains of cyclin-dependent kinase inhibitory proteins block the phosphorylation of cdk2/Cyclin E by the CDK-activating kinase | Q40881948 | ||
| Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase | Q42491855 | ||
| Revisiting purine-histidine cross-pathway regulation in Saccharomyces cerevisiae: a central role for a small molecule | Q42871214 | ||
| Metabolic intermediates selectively stimulate transcription factor interaction and modulate phosphate and purine pathways | Q43106464 | ||
| Ubiquitination of histone H2B by Rad6 is required for efficient Dot1-mediated methylation of histone H3 lysine 79. | Q44094473 | ||
| Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression. | Q46693645 | ||
| The tumor suppressor CDC73 interacts with the ring finger proteins RNF20 and RNF40 and is required for the maintenance of histone 2B monoubiquitination | Q50336173 | ||
| A rapid permeabilization procedure for accurate quantitative determination of beta-galactosidase activity in yeast cells | Q71693241 | ||
| Transcriptional activation via sequential histone H2B ubiquitylation and deubiquitylation, mediated by SAGA-associated Ubp8. | Q27933975 | ||
| A conserved RING finger protein required for histone H2B monoubiquitination and cell size control. | Q27934010 | ||
| A role for H2B ubiquitylation in DNA replication | Q27934274 | ||
| Yeast AMP pathway genes respond to adenine through regulated synthesis of a metabolic intermediate. | Q27934882 | ||
| Activation of transcription by metabolic intermediates of the pyrimidine biosynthetic pathway | Q27937077 | ||
| Identification of yeast and human 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAr) transporters | Q27938996 | ||
| In vitro transcriptional activation by a metabolic intermediate: activation by Leu3 depends on alpha-isopropylmalate | Q27939351 | ||
| Getting started with yeast | Q28131602 | ||
| Modulation of ATP-dependent chromatin-remodeling complexes by inositol polyphosphates | Q28215042 | ||
| Control of cell cycle transcription during G1 and S phases | Q28295030 | ||
| The genetic landscape of the childhood cancer medulloblastoma | Q28301196 | ||
| Inactivating CUX1 mutations promote tumorigenesis | Q28303563 | ||
| Role of the myb-like protein bas1p in Saccharomyces cerevisiae: a proteome analysis | Q28611260 | ||
| Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation | Q28647313 | ||
| Coupling of glucose deprivation with impaired histone H2B monoubiquitination in tumors | Q28729926 | ||
| Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast | Q29617217 | ||
| Rad6-dependent ubiquitination of histone H2B in yeast | Q29617525 | ||
| An essential G1 function for cyclin-like proteins in yeast | Q29620232 | ||
| Gene silencing: trans-histone regulatory pathway in chromatin | Q30309681 | ||
| Heat-induced cell cycle arrest of Saccharomyces cerevisiae: involvement of the RAD6/UBC2 and WSC2 genes in its reversal | Q30710761 | ||
| Chromatin signaling to kinetochores: transregulation of Dam1 methylation by histone H2B ubiquitination | Q33285644 | ||
| Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II study | Q33404763 | ||
| To cycle or not to cycle: a critical decision in cancer. | Q33957955 | ||
| Methylation of histone H3 by COMPASS requires ubiquitination of histone H2B by Rad6. | Q34133875 | ||
| G1 cell-cycle control and cancer | Q34368858 | ||
| Discovery of mutations in Saccharomyces cerevisiae by pooled linkage analysis and whole-genome sequencing | Q34386830 | ||
| The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development | Q34493999 | ||
| Positive feedback in the activation of G1 cyclins in yeast | Q34754139 | ||
| A chemical-genetic screen to unravel the genetic network of CDC28/CDK1 links ubiquitin and Rad6-Bre1 to cell cycle progression | Q35558616 | ||
| Linking cell cycle to histone modifications: SBF and H2B monoubiquitination machinery and cell-cycle regulation of H3K79 dimethylation | Q35568111 | ||
| Approaches to identifying synthetic lethal interactions in cancer. | Q35647469 | ||
| Disruption of Nucleotide Homeostasis by the Antiproliferative Drug 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside Monophosphate (AICAR). | Q36092969 | ||
| Identification of aneuploidy-selective antiproliferation compounds | Q36493649 | ||
| Chromatin challenges during DNA replication and repair | Q36744476 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1447-1460 | |
| P577 | publication date | 2016-10-05 | |
| P1433 | published in | Genetics | Q3100575 |
| P1476 | title | Chemo-Genetic Interactions Between Histone Modification and the Antiproliferation Drug AICAR Are Conserved in Yeast and Humans | |
| P478 | volume | 204 |
| Q90926961 | A Road Map to Personalizing Targeted Cancer Therapies Using Synthetic Lethality |
| Q55128561 | How Surrogate and Chemical Genetics in Model Organisms Can Suggest Therapies for Human Genetic Diseases. |
| Q92760873 | KMT2D deficiency enhances the anti-cancer activity of L48H37 in pancreatic ductal adenocarcinoma |
| Q93380778 | Metabolomics and proteomics identify the toxic form and the associated cellular binding targets of the anti-proliferative drug AICAR |
| Q88551058 | Multiple chemo-genetic interactions between a toxic metabolite and the ubiquitin pathway in yeast |
| Q61813974 | Yeast to Study Human Purine Metabolism Diseases |
Search more.